牛唐2021-03-31 09:44
$灿菲特生物制药(CANF)$ 的药物Piclidenoson和Namodenoson在现有的六份分销协议中,剩余的潜在里程碑付款高达约1.3亿美元,外加两位数的净销售额分成。$新泰医药(MDGL)$ $泰格医药(SZ300347)$查看全文
$CAN-FITE BIOPHARMA LTD(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-06-19 AccNo: 0001213900-17-006599 Size: 720 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2017-06-14 AccNo: 0001213900-17-006454 Size: 598 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ EFFECT - Notice of Effectiveness Filed: 2017-06-13 AccNo: 9999999995-17-001523 Size: 1 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-06-08 AccNo: 0001213900-17-006237 Size: 28 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-06-08 AccNo: 0001213900-17-006237 Size: 28 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-06-05 AccNo: 0001213900-17-006140 Size: 33 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-06-01 AccNo: 0001213900-17-006037 Size: 28 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ F-1 - Registration statement for certain foreign private issuers Filed: 2017-05-30 AccNo: 0001213900-17-005943 Size: 898 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Filed: 2017-05-30 AccNo: 0001213900-17-005936 Size: 112 KB 网页链接
$CAN-FITE BIOPHARMA LTD(CANF)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2017-05-22 AccNo: 0001213900-17-005595 Size: 62 KB 网页链接